Media
News
Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.
Health Canada approves VITRAKVI® (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion
Bayer Fund to provide nearly $100,000 in scholarships to eligible Canadian high school students in 2019
Bayer Inc. investing $500,000 in STEM education for Canadian youth through Let’s Talk Science